E-LIB Suche - Ergebnisse für: Litière, S

1

Early discontinuation of PD-1 blockade upon achieving a com..:

Mulder, E. E. A. P. ; de Joode, K. ; Litière, S....
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

2

Prognostic relevance of distant metastases versus locally a..:

Verschoor, A.J. ; Litière, S. ; Marréaud, S....
European Journal of Cancer. 94 (2018) - p. 187-198 , 2018

Link: https://doi.org/10.1016/..

3

A transatlantic perspective on the integration of immuno-on..:

Morfouace, M. ; Hewitt, S.M. ; Salgado, R....
Seminars in Cancer Biology. 52 (2018) - p. 158-165 , 2018

Link: https://doi.org/10.1016/..

4

European Organisation for Research and Treatment of Cancer ..:

Touati, N. ; Schöffski, P. ; Litière, S....
Clinical Oncology. 30 (2018) 7 - p. 448-454 , 2018

Link: https://doi.org/10.1016/..

5

Trasutuzumab versus observation for high-risk, non-metastat..:

Ignatiadis, M. ; Litiere, S. ; Rothe, F....
European Journal of Cancer. 92 (2018) - p. S7 , 2018

Link: https://doi.org/10.1016/..

6

Immunohistochemical versus molecular (BluePrint and MammaPr..:

for the MINDACT investigators ; Viale, G. ; de Snoo, F. A....
Breast Cancer Research and Treatment. 167 (2017) 1 - p. 123-131 , 2017

Link: https://doi.org/10.1007/..

7

Characterisation of multifocal breast cancer using the 70-g..:

Aalders, K.C. ; Kuijer, A. ; Straver, M.E....
European Journal of Cancer. 79 (2017) - p. 98-105 , 2017

Link: https://doi.org/10.1016/..

8

Investigating the heterogeneity of alkylating agents' effic..:

Fresneau, Brice ; Hackshaw, A. ; Hawkins, D.S....
Pediatric Blood & Cancer. 64 (2017) 8 - p. , 2017

Link: https://doi.org/10.1002/..

9

Impact of chemotherapy in uterine sarcoma (UtS): review of ..:

Ray-Coquard, I. ; Rizzo, E. ; Blay, J.Y....
Gynecologic Oncology. 142 (2016) 1 - p. 95-101 , 2016

Link: https://doi.org/10.1016/..

10

Outcome of uterine sarcoma patients treated with pazopanib:..:

Benson, C. ; Ray-Coquard, I. ; Sleijfer, S....
Gynecologic Oncology. 142 (2016) 1 - p. 89-94 , 2016

Link: https://doi.org/10.1016/..

11

3401 Absence of progression, not extent of remission define..:

Grünwald, V. ; Litiere, S. ; Young, R.J....
European Journal of Cancer. 51 (2015) - p. S688 , 2015

Link: https://doi.org/10.1016/..

12

Hypertension (HTN) as a potential biomarker of efficacy in ..:

Duffaud, F. ; Sleijfer, S. ; Litière, S....
European Journal of Cancer. 51 (2015) 17 - p. 2615-2623 , 2015

Link: https://doi.org/10.1016/..

13

3439 Prognostic factors in soft tissue sarcoma patients wit..:

Lindner, L. ; Litiere, S. ; Sleijfer, S....
European Journal of Cancer. 51 (2015) - p. S701 , 2015

Link: https://doi.org/10.1016/..

14

A phase IIb multicentre study comparing the efficacy of tra..:

Bui-Nguyen, B. ; Butrynski, J.E. ; Penel, N....
European Journal of Cancer. 51 (2015) 10 - p. 1312-1320 , 2015

Link: https://doi.org/10.1016/..

15

First-line anthracycline-based chemotherapy for angiosarcom..:

Young, R.J. ; Natukunda, A. ; Litière, S....
European Journal of Cancer. 50 (2014) 18 - p. 3178-3186 , 2014

Link: https://doi.org/10.1016/..